Skip to content
Research Article Open access CC BY 4.0

Assessment of Thrombolytic Activity of Selected Species from Lamiaceae Family Growing Naturally in Kurdistan Region\Iraq Using In-vitro Model

Lana Yousif Mutalib

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 1–5 · Published 6 Oct 2015

10.9734/JAMPS/2015/20550

Abstract

Aims: The present study was aimed to assess most commonly used medicinal plant belong to Lamiaceae family for their thrombolytic activity. Place and Duration of the Study: Pharmacy College\ Hawler Medical University, June, 2015. Methodology: Dried leaf part ethanolic extracts of selected species have been evaluated for their thrombolytic activity using fresh human blood specimen at concentrations of 200, 400, 600, 800 and 1000 µg\ml, streptokinase drug and distilled water were incorporated in the study as control positive and negative, respectively. Results: Showed significant thrombolytic activity of leaf extracts at all tested concentrations in comparison with control negative distilled water (P < 0.01), highest clot lysis activity were recorded for Salvia officinalis leaf extract (68.43±1.457%) and minimum activity were exhibited by Rosmarinus officinalis leaf extract (49.27±3.256%). Salvia officinalis and Thymus vulgaris expressed significant thrombolytic activity in comparison with control positive streptokinase            (P < 0.05) at highest tested dose concentration (1000 µg\ml). Conclusion: Selected species from Lamiaceae plant family can open a venue for production of thrombolytic drugs derived from natural source with greatest activity and lowest adverse effects.

Thrombolytic drugs Salvia officinalis Thymus vulgaris Rosmarinus officinalis

Cited by 2

Exploring Lamiaceae-derived bioactive compounds as nature’s arsenal for sustainable pest management

Muhammad Ali, Abrar Muhammad, Zemian Lin · Phytochemistry Reviews · 2024

Exploration of Lamiaceae in Cardio Vascular Diseases and Functional Foods: Medicine as Food and Food as Medicine

Ishani Chakrabartty, Yugal Kishore Mohanta, Amilia Nongbet · Frontiers in Pharmacology · 2022

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.